Which is better, LMAT or NNNN?

On the Buffett-Fit framework, Anbio Biotechnology Class A Ordinary Shares (NNNN) currently grades higher than LMAT — 58/100 (C grade) vs 77/100 (B). That said, "better" depends on which framework you trust — LMAT wins on Warren Buffett, Benjamin Graham, and Joel Greenblatt; NNNN wins on Philip Fisher, Peter Lynch, Charlie Munger, and Terry Smith. The full pillar breakdown is on this page.

Should I buy LMAT or NNNN?

This page is an educational comparison, not investment advice. Both LMAT and NNNN are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is LMAT better than NNNN for value investing?

On the Buffett-style value-investing framework, NNNN currently grades higher — 77/100 vs 58/100, a 19-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between LMAT and NNNN on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). LMAT currently scores 77/100 (B grade); NNNN scores 58/100 (C grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, LMAT or NNNN?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. LMAT and NNNN are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, LMAT or NNNN?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are LMAT and NNNN both Healthcare stocks?

Yes — both LeMaitre Vascular, Inc. (LMAT) and Anbio Biotechnology Class A Ordinary Shares (NNNN) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this LMAT vs NNNN comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

LeMaitre Vascular

Anbio Biotechnology

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

LMAT

LeMaitre Vascular

Market cap

$2.27B

Sector

Healthcare

NNNN

Anbio Biotechnology

Market cap

$1.43B

Sector

Healthcare

Overall winner

Anbio Biotechnology NNNN

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

Strategy	LMAT	NNNN	Winner
Warren Buffett	77B	58C	LMAT
Benjamin Graham	89A	87A	LMAT
Philip Fisher

Side-by-side metrics

Metric	LMAT	NNNN
Market cap	$2.27B	$1.43B
P/E (TTM)	37.1x	171.9x
EV/EBIT	36.6x	212.9x
ROIC (TTM)	9.43%	21.48%
Gross margin	72.39%	87.06%
Net margin	24.35%	73.75%
Revenue CAGR 5y	12.75%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

LMAT leads on

Dividend yield0.84%vs 0.0%+100%
EV/EBIT36.6xvs 212.9x+83%
P/E (TTM)37.1xvs 171.9x+78%
Market cap$2.27Bvs $1.43B

More like LMAT

LMAT vs IDXX LMAT vs MTD LMAT vs HALO LMAT vs HRMY LMAT vs RPRX LMAT vs GMAB

More like NNNN

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.